GAS5 and metastatic malignant neoplasm in the lymph nodes: In the current study, we discovered that the lncRNA GAS5-AS1 was downregulated in NSCLC tumors as compared to the adjacent normal lung tissues, and the expression of GAS5-AS1 was significantly lower in NSCLC patients with later stages of tumors and lymph node metastasis.